Exozymes (EXOZ) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $4.00, -13.04% vs the prior close of $4.60.
- Volume 24.40K shares, 3.7x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
EXOZ slides 13.0% to $4.00, a 52-week low on 3.7x normal volume. Closed at $4.00, -13.04% vs the prior close of $4.60. Day range $3.70–$4.88, opened at $4.60.
EXOZ daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — EXOZ slides 13.0% to $4.00, a 52-week low on 3.7x normal volume
- Closed at $4.00, -13.04% vs the prior close of $4.60. Day range $3.70–$4.88, opened at $4.60.
- Volume was 24.40K shares, 3.7x its 50-day average of 6.67K — unusually heavy trading.
- Price is -34.3% vs its 50-day average ($6.09) and -50.7% vs its 200-day average ($8.11).
- 52-week range $3.70–$18.40; today's close sits at 2% of that range, 78.3% below the 52-week high.
Oct 14, 2026 — EXOZ ends flat (+0.2%) to $4.60
- Closed at $4.60, +0.22% vs the prior close of $4.59. Day range $4.51–$4.80, opened at $4.51.
- Volume was 7.60K shares, 1.2x its 50-day average of 6.58K.
- Price is -24.8% vs its 50-day average ($6.12) and -43.6% vs its 200-day average ($8.15).
- 52-week range $4.35–$18.40; today's close sits at 2% of that range, 75.0% below the 52-week high.
Oct 13, 2026 — EXOZ slides 9.1% to $4.59, a 1-month low on 3.2x normal volume
- Closed at $4.59, -9.11% vs the prior close of $5.05. Day range $4.55–$5.07, opened at $5.05.
- Volume was 20.60K shares, 3.2x its 50-day average of 6.42K — unusually heavy trading.
- Price is -25.0% vs its 50-day average ($6.12) and -43.9% vs its 200-day average ($8.19).
- 52-week range $4.35–$18.40; today's close sits at 2% of that range, 75.1% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — EXOZ slides 3.8% to $5.05, a 1-month low, 3 down days in a row
- Closed at $5.05, -3.81% vs the prior close of $5.25. Day range $5.05–$5.30, opened at $5.30.
- Volume was 9.40K shares, 1.5x its 50-day average of 6.28K.
- Price is -17.5% vs its 50-day average ($6.12) and -38.6% vs its 200-day average ($8.23).
- 52-week range $4.35–$18.40; today's close sits at 5% of that range, 72.6% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — EXOZ dips 0.4% to $5.25, a 1-month low
- Closed at $5.25, -0.38% vs the prior close of $5.27. Day range $5.25–$5.41, opened at $5.34.
- Volume was 1.00K shares, 0.2x its 50-day average of 6.35K — lighter than usual.
- Price is -14.1% vs its 50-day average ($6.11) and -36.5% vs its 200-day average ($8.26).
- 52-week range $4.35–$18.40; today's close sits at 6% of that range, 71.5% below the 52-week high.
- SEC filings that day: 8-K.
Oct 8, 2026 — EXOZ slides 4.9% to $5.27, a 1-month low on 3.7x normal volume
- Closed at $5.27, -4.87% vs the prior close of $5.54. Day range $5.27–$6.34, opened at $5.69.
- Volume was 22.00K shares, 3.7x its 50-day average of 5.99K — unusually heavy trading.
- Price is -13.6% vs its 50-day average ($6.10) and -36.5% vs its 200-day average ($8.30).
- 52-week range $4.35–$18.40; today's close sits at 7% of that range, 71.4% below the 52-week high.
Oct 7, 2026 — EXOZ rises 0.4% to $5.54
- Closed at $5.54, +0.36% vs the prior close of $5.52. Day range $5.52–$5.71, opened at $5.55.
- Volume was 7.60K shares, 1.3x its 50-day average of 5.99K.
- Price is -8.9% vs its 50-day average ($6.08) and -33.5% vs its 200-day average ($8.33).
- 52-week range $4.35–$18.40; today's close sits at 8% of that range, 69.9% below the 52-week high.
Oct 6, 2026 — EXOZ ends flat (+0.0%) to $5.52
- Closed at $5.52, +0.00% vs the prior close of $5.52. Day range $5.52–$5.72, opened at $5.64.
- Volume was 1.80K shares, 0.3x its 50-day average of 6.34K — lighter than usual.
- Price is -8.9% vs its 50-day average ($6.06) and -34.0% vs its 200-day average ($8.37).
- 52-week range $4.35–$18.40; today's close sits at 8% of that range, 70.0% below the 52-week high.
Oct 5, 2026 — EXOZ slides 4.3% to $5.52, a 1-month low
- Closed at $5.52, -4.33% vs the prior close of $5.77. Day range $5.51–$5.85, opened at $5.85.
- Volume was 4.40K shares, 0.7x its 50-day average of 6.37K.
- Price is -8.6% vs its 50-day average ($6.04) and -34.3% vs its 200-day average ($8.40).
- 52-week range $4.35–$18.40; today's close sits at 8% of that range, 70.0% below the 52-week high.
Oct 2, 2026 — EXOZ ends flat (+0.2%) to $5.77
- Closed at $5.77, +0.17% vs the prior close of $5.76. Day range $5.76–$6.00, opened at $5.87.
- Volume was 2.10K shares, 0.3x its 50-day average of 6.47K — lighter than usual.
- Price is -4.2% vs its 50-day average ($6.02) and -31.6% vs its 200-day average ($8.43).
- 52-week range $4.35–$18.40; today's close sits at 10% of that range, 68.6% below the 52-week high.
EXOZ latest news & SEC filings
Every SEC filing by or about EXOZ in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 28, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 28, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Heltzen Michael bought 251 shares at $7.35 (≈$1.84K) on Aug 26, 2026
- Heltzen Michael bought 250 shares at $7.60 (≈$1.90K) on Aug 26, 2026
- Heltzen Michael bought 4 shares at $7.58 (≈$30) on Aug 26, 2026
- Heltzen Michael bought 100 shares at $7.50 (≈$750) on Aug 25, 2026
- Heltzen Michael bought 250 shares at $7.52 (≈$1.88K) on Aug 25, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$2.88M (prior year -$2.36M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.33 (prior year -$0.28) (loss widened vs Jun 30, 2025)
Jul 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Jun 30, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jun 26, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade EXOZ
- How much it moves: over the last 20 sessions the average daily move was 3.10% (largest 13.0%). That is a volatile stock.
- Liquidity: about 9.00K shares (≈$36.00K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $4.00 vs a range of $3.70–$18.40 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 5 open-market buys, 2 sales; latest: Michael Heltzen bought 251 shares on Aug 26, 2026.
- Latest filings: 8-K Oct 9, 2026; 8-K Sep 18, 2026; 10-Q Aug 13, 2026.
- Share count: 9.28M shares outstanding (Aug 13, 2026), +10.7% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
EXOZ market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 4.60 | 4.88 | 3.70 | 4.00 | 24.40K |
| Oct 14, 2026 | 4.51 | 4.80 | 4.51 | 4.60 | 7.60K |
| Oct 13, 2026 | 5.05 | 5.07 | 4.55 | 4.59 | 20.60K |
| Oct 12, 2026 | 5.30 | 5.30 | 5.05 | 5.05 | 9.40K |
| Oct 9, 2026 | 5.34 | 5.41 | 5.25 | 5.25 | 1.00K |
| Oct 8, 2026 | 5.69 | 6.34 | 5.27 | 5.27 | 22.00K |
| Oct 7, 2026 | 5.55 | 5.71 | 5.52 | 5.54 | 7.60K |
| Oct 6, 2026 | 5.64 | 5.72 | 5.52 | 5.52 | 1.80K |
| Oct 5, 2026 | 5.85 | 5.85 | 5.51 | 5.52 | 4.40K |
| Oct 2, 2026 | 5.87 | 6.00 | 5.76 | 5.77 | 2.10K |
| Oct 1, 2026 | 5.76 | 5.76 | 5.76 | 5.76 | 1.00K |
| Sep 30, 2026 | 5.77 | 6.20 | 5.77 | 5.83 | 2.00K |
| Sep 29, 2026 | 6.06 | 6.10 | 6.06 | 6.10 | 2.00K |
| Sep 28, 2026 | 6.53 | 6.53 | 6.00 | 6.00 | 8.30K |
| Sep 25, 2026 | 6.37 | 6.66 | 6.12 | 6.24 | 9.20K |
| Sep 24, 2026 | 6.12 | 6.34 | 6.12 | 6.34 | 6.50K |
| Sep 23, 2026 | 6.44 | 6.90 | 6.11 | 6.38 | 11.90K |
| Sep 22, 2026 | 6.46 | 6.98 | 6.15 | 6.19 | 9.50K |
| Sep 21, 2026 | 6.43 | 6.99 | 6.11 | 6.14 | 12.40K |
| Sep 18, 2026 | 6.17 | 6.74 | 6.00 | 6.43 | 16.30K |
About Exozymes
Exozymes (EXOZ) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in MONROVIA, CA. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 2010788.
EXOZ board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael Heltzen | Chief Executive Officer | Sep 2, 2026 |
| Tyler Paz Korman | Chief Scientific Officer | Aug 25, 2026 |
| Fouad Nawaz | Vice President- Finance | Sep 17, 2026 |
| Paul Hideo Opgenorth | Vice President, Development | Apr 8, 2026 |
| Damien Alan Perriman | Chief Commercial Officer | Aug 25, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 26, 2026 | Michael Heltzen | Buy | 251 | $7.35 |
| Aug 26, 2026 | Michael Heltzen | Buy | 250 | $7.60 |
| Aug 26, 2026 | Michael Heltzen | Buy | 4 | $7.58 |
| Aug 25, 2026 | Michael Heltzen | Buy | 100 | $7.50 |
| Aug 25, 2026 | Michael Heltzen | Buy | 250 | $7.52 |
| Apr 9, 2026 | Tyler Paz Korman | Sale | 750 | $10.53 |
| Apr 8, 2026 | Tyler Paz Korman | Sale | 750 | $10.04 |
EXOZ financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-9.16M | -1.09 | $-6.50M |
| Dec 31, 2024 | — | $-5.86M | -0.89 | $-8.51M |
| Dec 31, 2023 | $70.07K | $-2.04M | -0.33 | $-1.18M |
Latest balance sheet: total assets $7.98M, total liabilities $4.33M, cash $5.65M (as of Jun 30, 2026).
EXOZ earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Argenx Se (ARGX)Biogen (BIIB)Halozyme Therapeutics (HALO)Revolution Medicines (RVMD)Recursion Pharmaceuticals (RXRX)ImmunityBio (IBRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on EXOZ
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.